The post Life Science Innovation in Washington State appeared first on Life Science Washington.

The WIN Mentoring Program gives promising early stage Washington Life Science and Global Health ventures world class advice and assistance through their most critical stages.

In this milestone-focused program, entrepreneurs are matched with an all-star team of seasoned volunteer advisors. Entrepreneurs receive professional advice from teams of professionals with deep and diverse expertise in commercialization and business execution.

WIN is modeled after two successful programs: MIT Venture Mentoring Service and Chicago Innovation Mentors, and was adapted to the unique needs of the Washington Life Science and Global Health community.

Click Here to learn more about the WIN Mentoring Program.

The post Life Science Washington Institute WIN Mentoring Program appeared first on Life Science Washington.

Policy Matters: Innovation Basics brings together more than 200 cross sector leaders and elected officials from all over the state to make connections, build bridges, and expand knowledge on key technologies. With this year’s theme of Innovation Basics, the event is broken down into five sessions:

• Blockchain
• Fusion
• Immunotherapy
• Power Grid
• Quantum

The post TechAlliance Policy Matters Summit: Immunotherapy Panel appeared first on Life Science Washington.

Life Science Washington Institute, Cooley, and APIS Health Angels are holding the second annual Startup Pitch Showcase on September 26 to highlight nine investor selected, promising young companies and provide current and aspiring investors education on life sciences-unique investment due-diligence.

Startups are invited to apply to present a three-minute, virtual, verbal pitch and will receive expert investor commentary provided by Minda Brusse, Leen Kawas, PhD, and Vikram Dendi immediately following. A mix of life science startups is sought, from those seeking seed investments to those ready to reach out to early-stage VC’s ($500k-$5M in investments sought). This is a great opportunity for investors and entrepreneurs to connect!

The post Life Science Startup Pitch Showcase appeared first on Life Science Washington.

The rapid evolution of modern medicine has spurred incredible advancements in vaccine and drug delivery. As the pace of innovation and drug discovery continues to accelerate, medical device R&D organizations have had to keep pace to effectively produce mechanisms to deliver these critical and emerging treatments. In this DeviceConnect, we’ll hear directly from leaders who are innovating on the medical and delivery sides to meet modern needs and patient scenarios.

Speakers include:
– Saniya Ali, PhD, Chief Technology Officer and Co-founder, Watershed Therapeutics
– Deborah H. Fuller, PhD, Professor, Department of Microbiology, University of Washington School of Medicine
– Manjari Lal, PhD, Program Advisor, PATH
– Scott Thielman, Chief Technology Officer, Product Creation Studio

The post DeviceConnect: Novel Delivery Mechanisms for Modern Medicine appeared first on Life Science Washington.

Things are optimistic in the life sciences industry, as both venture capital Cellular therapies are reshaping the therapeutic landscape, representing one of the highest growth sectors for FDA IND applications, spurring some of the most recognized young companies, producing several high-value cancer drugs, and transforming lives. The Seattle area has led the development from the start with seminal work by Dendreon, bringing to market the first FDA-approved immunotherapy made from a patient’s own immune cells (Provenge), as well as pioneering advances in chimeric antigen receptor (CAR) T cell therapy by the Hutch, Seattle Children’s Research Institute and Juno Therapeutics.

Today, the region remains at the forefront, supporting the development and launch of two commercially available CAR T cell products, Breyanzi (Juno/Celgene/Bristol Myers Squibb) and Abecma (2seventy bio (formerly bluebird bio)/Celgene/Bristol Myers Squibb), and delivering innovative cell therapies to put more patients on the path to a cure. Young cellular therapy companies with roots in Seattle such as, Sana, 2seventy bio, Umoja, GentiBio, Notch Therapeutics, Century Therapeutics, Gilead, Sonoma Bio, Lyell, among others promise to usher in the next era of innovation. The science is established. The patient benefits are real. The possibilities are endless.

Speakers include:

-Charlotte Schubert, PhD, Reporter, GeekWire – Moderator
-Tina Albertson, PhD, Chief Medical Officer and Head of Development, Lyell Immunopharma
-Alicia Collins, Executive Director, Bristol Myers Squibb
-Heidi Hagen,Chief Technology Officer, Sonoma Biotherapeutics
-Michael Jensen, MD, Vice President and Chief Therapeutics Officer, Seattle Children’s Health System

The post Cellular Therapy Series Part I: How Engineered Cellular Therapies are Reshaping Medicine appeared first on Life Science Washington.

Things are optimistic in the life sciences industry, as both venture capital funding in the sector and demand for laboratory space are at an all-time high. These trends, along with a 23.5% increase in jobs in the field from 2015-2019, is giving those in the sector reason to believe that 2022 is set to grow life sciences even more.

So what’s ahead for the region’s booming biotech market? Join us to hear from a panel of experts on what impacts they’re continuing to see from COVID, how they are dealing with the challenges of limited real estate options and workforce demands, and what the future will hold for this industry.

The post Seattle Metro Chamber – Executive Speaker Series: Life Sciences appeared first on Life Science Washington.

The post A Conversation on Diversity appeared first on Life Science Washington.

Life Science Washington’s annual HR conference was created to inspire, educate and energize the professionals that provide unwavering support for those whose work is focused on improving and saving lives. This year we are delighted to introduce LSW HR Connect – a community available to HR professionals belonging to LSW member life science companies and research institutions. In addition, we are excited to introduce the cloud-based Mobilize platform. This new tool will allow for the confidential sharing of ideas and resources as well as allow group members to create and administer polls without a middleman.

The post 2nd Annual HR Conference appeared first on Life Science Washington.

Life Science Washington is proud to present the Washington State Life Science Summit: Celebrating Success and Sustaining Our Growth, where hundreds of leaders in the Washington life science industry gather to celebrate our industry’s successes, discuss current challenges, and learn about coming opportunities.

The post Washington State Life Science Summit 2020 appeared first on Life Science Washington.